Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Clinical trial NCT04872478 · RECRUITING

Trial details

NCT number: NCT04872478
Sponsor: Meryx, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Mixed Phenotype Acute Leukemia

Start date: 2022-04-01
Primary completion: 2026-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.